According to a Moderna statement, the booster stimulated a greater than ... still ongoing however about the possibility of offering a fourth shot more widely to protect against a resurgence ...

Government vaccine advisers are meeting to decide if the recipe for COVID-19 vaccines needs updating for this fall and winter ...

WASHINGTON – Robert F. Kennedy Jr. clinched the political support needed to become the nation’s top health official by pledging to work within the decades-old federal system for approval and use of ...

Vaccine producers BioNTech and Moderna have both said they could ... and potentially a fourth booster dose to be safe.

There’s evidence protection can wane particularly in higher-risk groups, and for them another booster “will help save lives,” FDA vaccine chief Dr. Peter Marks said. For all the attention on who ...

Cheng Xin / Getty Images Shares of Moderna surged to lead S&P 500 gainers in early afternoon trading Tuesday, hours after the Food and Drug Administration (FDA) issued new guidance for COVID-19 ...

Shares of Moderna surged to lead S&P 500 gainers Tuesday after the Food and Drug Administration issued new guidance for COVID ...

Moderna, Inc. (NASDAQ ... a sizable majority of the population would still be able to obtain annual booster shots, even though their availability this fall would be restricted to older adults ...

Despite this week's climb, shares of Moderna have lost about a third of their value this year so far Shares of Moderna surged to lead S&P 500 gainers in early afternoon trading Tuesday ...

The FDA plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under 65.

Moderna, Inc. (NASDAQ:MRNA) shares soared to the top of the ... According to the FDA's announcement, a sizable majority of the population would still be able to obtain annual booster shots, even ...

Moderna, Inc. (NASDAQ:MRNA) shares soared to the top of the S&P 500 gainers in early afternoon trading on May 20, surging by ...